BallAM, SmithKM: Optimizing transdermal drug therapy. Am J Health Syst Pharm, 2008; 65:1337–1346.
2.
SkaerTL: Practice guidelines for transdermal opioids in malignant pain. Drugs, 2004; 64:2629–2638.
3.
KokubunH, MatobaM, OkazakiM, et al.: Evaluation of the 2.5 mg fentanyl patch, applied using the half-side application procedure in patients with cancer pain. Yakugaku Zasshi, 2008; 128:447–450.
4.
ArnetI, SchacherS, BalmerE, et al.: Poor adhesion of fentanyl transdermal patches may mimic end-of-dosage failure after 48 hours and prompt early patch replacement in hospitalized cancer pain patients. J Pain Res, 2016; 9:993–999.
